跳至主要内容
临床试验/NCT06130475
NCT06130475已完成不适用

Effects of Oral Rehydration Solution on Dehydration Recovery in Adults

Abbott Nutrition2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2024年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
26
试验地点
2
主要终点
Plasma Volume

研究概览

简要总结

This is a prospective, randomized, controlled, blinded, crossover study to evaluate the effects of an oral hydration solution.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participant is 18 to 40 years of age.
  • Participant has a body mass index (BMI) ≥ 18 and ≤ 30 kg/m2
  • Participant reports having a moderate to heavy sweat rate when physically exerted or in extreme heat
  • Participant is male or non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit.
  • Participant has a systolic blood pressure <130 mm Hg and a diastolic blood pressure < 90 mm Hg without the use of anti-hypertensive medications.
  • Participant reports no predisposing cardiovascular conditions.
  • If female, participant has a regular menstrual cycle
  • Participant is willing to consume grape-flavored beverages during the study.
  • If participant is on chronic medication the dosage must be constant for at least 2 months prior to enrollment and able to maintain medication, type and dose throughout duration of study
  • Participant is weight-stable for the two months prior to screening visit
  • Participant has voluntarily signed and dated an informed consent form (ICF), approved by an IRB, and provided applicable privacy regulation authorization prior to any participation in the study
  • Participant has no known intolerance or allergy to ingredients in study products
  • Participant is willing to refrain from using saunas or hot tubs for the duration of the study
  • Participant is able and willing to follow study procedures and complete any forms or assessments needed during the study

排除标准

  • Participant is a current or recent (the past 8 weeks) participant in a weight-conscious sport such as but not limited to wrestling, powerlifting, boxing, rowing, gymnastics or any martial arts, with participation defined as ≥ 3x weekly training
  • Participant is currently, and for the past 4 weeks or longer: running >40 miles per week on average, cycling >80 miles per week on average or swimming >20,000 yards per week on average
  • Participant is participating in another study that has not been approved as a concomitant study
  • Participant has used a sauna in the past 4 weeks
  • Participant uses any form of tobacco or nicotine, or other controlled substance not prescribed by a physician
  • Participant has previous history with heat illness or injury that resulted in a visit to a medical center in the past 12 months
  • Participant has an eating disorder, severe dementia or delirium, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study protocol procedures
  • Participant is currently taking or has taken antibiotics within 6 weeks of enrollment
  • Participant is currently taking or has taken a diuretic within 1 week of enrollment
  • Participant has been diagnosed with the following:
  • Acute or chronic infections including but not restricted to respiratory infections, diarrhea, Hepatitis B or C, HIV infection or tuberculosis
  • Severe gastrointestinal disorders such as celiac disease, short bowel syndrome, pancreatic insufficiency, or cystic fibrosis
  • Metabolic [including diabetes], renal, hepatic, or respiratory disease
  • Active malignancy
  • Polycystic ovary disease
  • Any other clinically significant medical condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study

结局指标

主要结局

Plasma Volume

时间窗: Through Study completion, an average of 2 weeks

Calculated Change in Plasma Volume

次要结局

  • Blood Biomarker - Plasma Electrolyte Concentration(Through Study completion, an average of 2 weeks)
  • Blood Biomarker - Glucose Concentration(Through Study completion, an average of 2 weeks)
  • Body Mass(Through Study completion, an average of 2 weeks)
  • Hydration Status Urine(Through Study completion, an average of 2 weeks)
  • Body Temperature(Through Study completion, an average of 2 weeks)
  • Blood Biomarker - Plasma Osmolality(Through Study completion, an average of 2 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验